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1. Introduction 
Isolated islets of Langerhans release somatostatin in 
response to glucose [l] , CAMP [2] , Lu-ketoisocaproic 
acid, glucagon and theophylline [3]. The aim of the 
present study was to investigate the interactions that 
might exist between the secretion of somatostatin and 
insulin, i.e., a possible D-cell/B-cell interrelationship. 
A static incubation system, as previously used 
[l-3], is of limited help for this purpose because it 
does not give information on the dynamics of the 
respective release processes. Therefore, the kinetics 
of somatostatin and insulin release from isolated rat 
islets were investigated in a perifusion system. 
2. Materials and methods 
Fed, male Wistar rats (220-270 g) were used 
throughout the study. Bovine serum albumin was 
purchased from Behringwerke A. G., Marburg, FRG; 
12SI-labeled porcine insulin (spec. act. 1 SO-200 mCi/ 
mg) from Farbwerke Hoechst A. G., Frankfurt, FRG; 
crystalline rat insulin from Serono, Freiburg, FRG; 
collagenase from Worthington Biochemical Co., USA. 
Islets were isolated from rat pancreas by collagenase 
2 h after intraperitoneal administration of 0.6 ml 
pilocarpine hydrochloride (2% w/v), as previously 
described [4,5] and perifused for 90 min with Krebs- 
Ringer bicarbonate buffer (0.2 mg/ml BSA; 1000 
KIU/ml Trasylol @), 2 mM or 25 mM glucose with or 
without 5 mM theophylline, pH 7.4,37”C), 0.9 ml/min 
flow rate, 300 islets/perifusion [6] . All perifusions were 
preceded by a preperifusion period of 30 min with 
2 mM glucose. 
Insulin release into the medium was determined 
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by radioimmunoassay with rat insulin as reference 
standard. Insulin release is expressed as ng/300 
islets/2 min. Somatostatin was measured by radio- 
immunoassay as described [3]. The release of 
somatostatin is expressed as pg/300 islets/2 min. 
Statistical analysis was by Student’s I-test based on 
paired comparisons. 
3. Results 
Figure 1 shows the dynamics of somatostatin and 
insulin release from rat islets perifused for 3 periods 
of 30 min with a medium containing first 2 mM, then 
25 mM and thereafter 2 mM glucose. An increase in 
the concentration of glucose from 2-25 mM was 
associated with an immediate increase of insulin 
release. This release was biphasic, with a rapid first 
peak and a sustained second peak. Somatostatin 
release likewise increased in response to 25 mM 
glucose (148 + 18 pg/300 islets/30 min versus 
214 f 35 pg/300 islets/30 min; P < 0.0125). However, 
this increase was significantly less pronounced than 
the increase in the release of insulin. 
As expected, insulin secretion decreased immediately 
when the glucose concentration was lowered from 
25-2 mM. This decrease was associated with a 
transient increase of somatostatin secretion (176 +_ 34 
pg/300 islets from 60-68 min versus 70 + 14 pg/300 
islets during the preceding 8 min; P < 0.01). 
The,effect of theophylline on somatostatin and 
insulin release is shown in fig.2. Theophylline (5 mM) 
significantly enhanced the stimulatory effect of 25 mM 
glucose on the secretion of somatostatin and insulin. 
In the presence of 5 mM theophylline plus 25 mM 
glucose 639 f 115 pg somatostatin/300 islets/30 min 
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Fig.1. Effect of glucose on the kinetics of somatostatin (shaded area) and insulin release (light area) from isolated perifused rat 
pancreatic islets. Batches of 300 islets were perifused for 3 periods of 30 min each with Krebs-Ringer bicarbonate buffer con- 
taining 2 mM or 25 mM glucose. Two minute fractions are plotted. Mean values + SEM obtained from 10 experiments are shown. 
Significantly less somatostatin is released in the presence of 2 mM glucose (l-30 min) than in the presence of 25 mM glucose 
(31-60 min) (P < 0.0125). The sudden decline of the glucose concentration from 25-2 mM is associated with a decrease of 
insulin but an increase of somatostatin release (60-68 min) versus the preceding 8 min; P < 0.01). 
were released versus 214 + 35 pg/300 islets/30 min 
in the presence of 25 mM glucose without theo- 
phylline (fig.1, period 2 versus fig.2, period 2; 
P < 0.01). If 5 mM theophylline and 25 mM glucose 
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in the medium were replaced by 2 mM glucose, 
insulin secretion declined immediately, but somato- 
statin release with a lag period of about 4 min (fig.2, 
period 3). 
4. Discussion 
Release of somatostatin from isolated rat pan- 
creatic islets by glucose could be demonstrated in a 
Fig.2. Effect of theophylline on glucose-induced somatostatin 
(shaded area) and insulin release (light area) from isolated 
perifused rat pancreatic islets. Batches of 300 islets were 
perifused for 3 periods of 30 min each with Krebs-Ringer 
bicarbonate buffer containing 2 mM glucose or 25 mM 
glucose plus 5 mM theophylline. Two minute fractions are 
plotted. Mean values + SEM obtained from 10 experiments 
are shown. Theophylline (5 mM) significantly enhanced the 
stimulatory effect of glucose (25 mM) on the secretion of 
somatostatin and insulin (period 2 versus period 2 in fig. 1; 
P < 0.01). 
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static incubation system [1,2] . However, it remained 
undecided whether glucose affects somatostatin 
release directly or whether its effect is mediated via 
insulin or other factors. An answer to this question 
could be expected from studies on the dynamics of 
somatostatin and insulin release. 
The stimulatory effect of glucose on the release 
of somatostatin has been confirmed (fig.1). Islets 
perifused first with a medium containing 2 mM 
glucose increased somatostatin release if the glucose 
concentration was subsequently raised to 25 mM. 
The dynamics of somatostatin and insulin release 
differed. Insulin release increased immediately in 
response to 25 mM glucose, and declined rapidly if 
the glucose concentration was lowered subsequently 
to 2 mM. Somatostatin release likewise increased in 
response to 25 mM glucose, although significantly 
less than the secretion of insulin. However, if the 
concentration of glucose was lowered from 25-2 mM, 
a dissociation occurred between the secretion of 
insulin and somatostatin. While the release of insulin 
declined immediately, somatostatin release increased 
for a period of about 8 min (fig.1). 
The sudden increase of somatostatin release, 
despite the decrease in the concentration of glucose 
suggests the removal of an inhibitory effect on the 
D-cell’s secretory mechanism. It is conceivable that 
factors associated with a high secretory activity of 
B-cells, such as insulin itself, ion fluxes, changes in the 
electrical activity or other phenomena are responsible 
for the inhibition of somatostatin release. This would 
explain why insulin and somatostatin release dissociate 
when the glucose concentration is suddenly decreased 
and why the stimulatory effect of a high (25 mM) 
glucose concentration on somatostatin release is only 
moderate. 
Despite reports to the contrary, evidence is 
accumulating that insulin lowers the availability of 
CAMP in various tissues (for review see ref. [7,8]). 
Whether the release of somatostatin is decreased via 
diminishing the availability of CAMP in D-cells is not 
known but compatible with the observation that 
theophylline enhances the effect of glucose on 
somatostatin release (fig.2). 
The replacement of 5 mM theophylline and 25 mM 
glucose in the medium by 2 mM glucose was associated 
with an immediate decrease in the release of insulin. 
Somatostatin release remained high for about 4 min, 
i.e., did not show the transient increase occurring from 
islets exposed to glucose without theophylline (fig.1 
and 2). This is understandable if the secretory 
mechanism of the D-cell is maximally stimulated by 
5 mM theophylline plus 25 mM glucose. One then 
would not expect a further increase in somatostatin 
release, despite the sudden decrease in the secretory 
activity of the B-cell, i.e., cessation of the inhibitory 
effect on somatostatin release. 
The present data thus suggest hat somatostatin 
release is stimulated by glucose and inhibited by 
phenomena associated with a high secretory activity 
of B-cells. Whether the increase of somatostatin 
release, which is associated with the sudden decrease 
in the concentration of glucose contributes to the 
decline of insulin secretion remains to be demonstrated. 
Such an effect seems possible, because exogenous 
somatostatin is known to inhibit the secretion of 
insulin in vitro [9-l 31 and in vivo [14-171. 
Endogenous somatostatin could have a similar 
effect because this peptide has been suggested to be 
a candidate paracrine transmitter substance with local 
action [ 181. To what extent secretory profiles of 
insulin and somatostatin reflect local changes in the 
concentrations of the hormones is not known. In 
addition, the interactions between insulin and somato- 
statin are likely to be influenced by other islet 
hormones such as glucagon and pancreatic polypeptide. 
This complicates the interpretation of the results. 
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